September 25, 2015

The Food and Drug Administration on Friday approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection) to improve blood sugar control in adults with diabetes mellitus. Both Tresiba and Ryzodeg are manufactured by Novo Nordisk.

August 31, 2015

The combination of resources is aimed at providing diabetes patients better tools for self-management and giving healthcare providers more tools to support patients, according to the companies. 

August 28, 2015

The Food and Drug Administration has a new diabetes treatment developed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co.

August 25, 2015

Glucose monitoring device company Dexcom announced Tuesday that the Food and Drug Administration had approved its G5 Mobile Continuous Glucose Monitoring System.

August 20, 2015

While the first retail clinics began to enter chronic disease management going back as early as 2010, these efforts have been ramped up considerably in recent years as payers look more aggressively to lower costs and health systems look to drive improved patient outcomes.

August 14, 2015

Nearly 13% of U.S. Hispanic adults are already diagnosed with diabetes, one of the highest prevalence rates among ethnic groups in the country.

August 5, 2015

Association is placing its support behind the Access To Quality Diabetes Education Act of 2015, versions of which are before both the House and the Senate.

August 5, 2015

 Data recently presented at t AADE15 suggests that people with type 2 diabetes can lower their blood sugar and benefit from following a structured, personalized self-monitoring blood glucose schedule even if they don’t require insulin.

June 15, 2015

As many as 42% of the patients with a pharmacist on their care team had at least one change to their blood pressure drugs, which leads to improved outcomes, study finds.

June 11, 2015

The Balance Rewards for healthy choices program gives users Balance Rewards points for logging blood pressure or weight loss, tracking daily activity and setting achievable goals.

May 29, 2015

Type-2 diabetes patients do better when a pharmacist is a part of their care team. 

May 22, 2015

The American Pharmacists Association Foundation’s diabetes management solution, the Patient Self-Management Credential for Diabetes, was highlighted at the Healthcare Leadership Council’s wellness briefing.

April 23, 2015

Publix announced that its pharmacies leaped past a major milestone this month, filling more than 50 million free prescriptions for its customers in the past eight years. 

April 22, 2015

Ahold USA’s COO James McCann earlier this year outlined the driving force behind the supermarket operator’s overarching initiatives — improve customer perceptions of its U.S. operations across quality and service, as well as price.

March 24, 2015

A new report by Shoppers Drug Mart and Great-West Life demonstrates the importance of pharmacist interventions in diabetes management.

February 26, 2015

Sanofi expands its portfolio of insulin therapy products with the introduction of the once-daily, long-acting Toujeo. 

February 3, 2015

Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co. on Monday announced that the Food and Drug Administration has approved Glyxambi (empagliflozin/linagliptin) tablets. 


January 6, 2015

People with type 1 diabetes who intensively control their blood glucose early in their disease are likely to live longer than those who do not.

December 11, 2014

The Little Clinic and UC Health have announced that they are expanding on their relationship to include diabetes management, beginning in December, inside seven pilot program locations.

November 17, 2014

Four-in-10 U.S. adults are expected to develop Type 2 diabetes at some point in their lifetime, according to a new study published in The Lancet Diabetes & Endocrinology in August, suggesting that as many as 126 million consumers will be looking for treatment options, including self-monitoring their condition at home.

November 11, 2014

In recognition of American Diabetes Month in November, Price Chopper has developed food- and health-related programs to help promote awareness on the issues surrounding diabetes and the people who are impacted by the disease.

November 10, 2014

Eli Lilly and Co. on Monday announced that its Type 2 diabetes treatment drug Trulicity (dulaglutide) , is now available in U.S. pharmacies. The drug is a once-weekly glucagon-like peptide-1 receptor agonist, and comes in a single-dose pen, which doesn't require the patient to mix, measure or handle the needle, the company said.

November 6, 2014

It is a common practice for adults with Type 1 or Type 2 diabetes to receive an offer for a free blood-glucose meter from manufacturers; however, satisfaction is significantly higher among meter users who are offered a choice from a selection of at least three free meter models than among those who are not offered a choice.

November 5, 2014

Novo Nordisk on Wednesday announced the relaunch of Cornerstones4Care, an online patient support platform for people living with diabetes.